10 Best Dividend Stocks with 5%+ Yields and Growing Cash Flows
Dividends have played a bigger role in equity returns than most people realize.
Pfizer Inc (PFE)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 104,964,427 | $2,947,401,125 | +103% | 1% |
| 2. | Marshall Wace LLP Paul Marshall And Ian Wace | 16,082,788 | $451,604,686 | +28% | 0.45% |
| 3. | Unisphere Establishment Hani Lazkani (Ceo) | 14,650,000 | $411,372,000 | 3.46% | |
| 4. | D E Shaw D. E. Shaw | 12,467,262 | $350,080,716 | +266% | 0.21% |
| 5. | 12,053,900 | $338,473,512 | -37% | 0.05% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $25.65 | 19,457 | $499,072.05 | 27,707 | 2025-02-13 | Filing | |
| $28.24 | 1,000 | $28,240.00 | 10,000 | 2024-10-30 | Filing | |
| $26.47 | 3,000 | $79,401.00 | 9,000 | 2023-12-15 | Filing | |
| $38.58 | 1,000 | $38,580.00 | 6,000 | 2023-05-08 | Filing | |
| $38.43 | 1,000 | $38,425.00 | 5,000 | 2023-05-05 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $25.93 | 2,500 | $64,825.00 | 11,850 | 2025-03-04 | Filing | |
| $28.66 | 5,154 | $147,713.64 | 8,582 | 2024-08-13 | Filing | |
| $40.02 | 9,912 | $396,678.24 | 9,003 | 2023-03-15 | Filing | |
| $53.96 | 4,218 | $227,603.28 | 10,846 | 2022-06-07 | Filing | |
| $50.50 | 4,000 | $202,000.00 | 15,064 | 2022-05-16 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 498,257,550 | $13,991,071,993 | 0.24% | |
| 2. | 369,430,012 | $10,373,594,737 | 0.25% | |
| 3. | 301,589,865 | $8,468,643,409 | 0.29% | |
| 4. | 133,561,742 | $3,736,517,296 | 0.23% | |
| 5. | 116,734,695 | $3,277,910,236 | 0.17% |
News See All
Jim Cramer’s Take on 24 Stocks: Cisco, Eli Lilly, and Ford
In this article, we will look at the stocks on which Jim Cramer shared his take, explaining that dot-com analogies do not hold up for this market.
10 Best High Volume Stocks to Invest In According to Hedge Funds
On May 4, Tom Lee, Fundstrat CIO & Head of Research, appeared on CNBC's 'Squawk Box' to discuss the latest market trends amidst ongoing geopolitical conflict.
Pfizer Inc. (NYSE:PFE) Q1 2026 Earnings Call Transcript
Operator: Good day, everyone, and welcome to Pfizer's First Quarter 2026 Earnings Conference Call. Today's call is being recorded.
25 Stocks on Jim Cramer’s Radar: Arm, Arista, and CoreWeave
In this article, we will look at the stocks on Jim Cramer’s radar on Mad Money as he discussed the upcoming earnings.
Guggenheim Reaffirms Buy on Pfizer (PFE) Ahead of Pipeline Catalysts
Pfizer Inc. (NYSE:PFE) ranks among the best low-risk investments in May 2026. On April 13, Guggenheim reaffirmed a Buy rating and a $36 price target for Pfizer Inc.
10 Best Low-Risk Investments in May 2026
On April 22, Tom Lee, Managing Partner and Head of Research at Fundstrat, spoke on CNBC Power Lunch and noted a favorable macro environment for stocks in 2026.
10 Innovative Dividend Stocks to Buy Right Now
According to a report by CMC Markets, research continues to show that stocks of innovative companies tend to outperform those of less innovative peers. Data from GlobalData highlights this trend.
10 Best Medical Stocks to Buy Under $30
On April 28, Reuters reported that the US Food and Drug Administration has introduced a new pilot program that would allow the agency to monitor clinical trial data in real time.
9 Most Active US Stocks to Buy Right Now
On April 29, Joe Amato, Neuberger President and CIO, joined 'Squawk Box' to discuss the current state of the capital markets, noting that while there has been a significant snapback rally following the...
Hedge Fund Resource Center